As 'Spamalot' returns to the Hollywood Pantages, Eric Idle says of absurdist comedy, 'these are the sort of times when we ...

President Donald Trump’s “good” hand doesn’t look so good. Trump, 79, showed off his non-dominant left hand during multiple public events at the White House on Monday, and it appeared a little worse ...

A highly sophisticated set of iPhone hijacking techniques has likely infected tens of thousands of phones or more. Clues suggest it was originally built for the US government. Security researchers at ...

Riot’s latest venture into the trading card game space with League of Legends’ Riftbound continues to grow with its second set, Spiritforged. The young TCG is holding its own with the likes of Disney ...

A venerable City of London institution is being snapped up by a U.S. asset manager in a nearly $14 billion deal that comes amid growing fears that AI will severely disrupt the finance sector.

OBERLIN, Ohio -- If summer break usually means sleeping in and wondering what comes next, Career Tech X has a different idea — one that involves rolling up sleeves, trying new skills and getting a ...

Taiwan Semiconductor is the primary chip supplier. Nvidia is the go-to computing unit provider. Broadcom's custom AI chips are an emerging alternative. Although there are fears of an AI bubble forming ...

Omaha Supernovas' Luka Slabe, Merritt Beason and Sarah Parsons full press conference after sweeping San Diego Mojo The Omaha Supernovas lost their second straight Major League Volleyball home match, ...

Photos appearing to show a hole and discoloration on President Donald Trump's hand have attracted scrutiny on social media as commentators speculate about his health. Writing on X, people shared ...

Hamza is a gaming enthusiast and a Writing Specialist from Pakistan. A firm believer in Keyboard/Mouse supremacy, he will play Tekken with WASD if you let him. He has been writing about games since ...

Close to two years after AbbVie handed over $48 million for the rights to Ose Immunotherapeutics’ inflammation drug, the Big Pharma now wants the French biotech to keep an eye on the asset for a while ...